AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
226.08
-2.63 (-1.15%)
At close: Dec 5, 2025, 4:00 PM EST
226.45
+0.37 (0.16%)
After-hours: Dec 5, 2025, 7:55 PM EST
AbbVie Stock Forecast
Stock Price Forecast
According to 17 professional analysts, the 12-month price target for AbbVie stock ranges from a low of $190 to a high of $289. The average analyst price target of $240.12 forecasts a 6.21% increase in the stock price over the next year.
Price Target: $240.12 (+6.21%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AbbVie stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 5 | 6 | 5 | 3 |
| Buy | 11 | 11 | 12 | 12 | 12 | 9 |
| Hold | 5 | 5 | 5 | 5 | 5 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 23 | 23 | 22 | 23 | 22 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $195 → $220 | Hold | Maintains | $195 → $220 | -2.69% | Nov 7, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $284 → $289 | Buy | Reiterates | $284 → $289 | +27.83% | Nov 5, 2025 |
| Citigroup | Citigroup | Hold Maintains $240 → $235 | Hold | Maintains | $240 → $235 | +3.95% | Nov 3, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $250 → $260 | Buy | Maintains | $250 → $260 | +15.00% | Nov 3, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $227 → $242 | Strong Buy | Maintains | $227 → $242 | +7.04% | Oct 20, 2025 |
Financial Forecast
Revenue This Year
62.18B
from 56.33B
Increased by 10.37%
Revenue Next Year
68.03B
from 62.18B
Increased by 9.41%
EPS This Year
10.86
from 2.39
Increased by 354.25%
EPS Next Year
14.53
from 10.86
Increased by 33.81%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 64.6B | 72.1B | ||||
| Avg | 62.2B | 68.0B | ||||
| Low | 59.6B | 64.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 14.7% | 16.0% | ||||
| Avg | 10.4% | 9.4% | ||||
| Low | 5.8% | 3.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 11.37 | 16.20 | ||||
| Avg | 10.86 | 14.53 | ||||
| Low | 10.38 | 12.75 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 375.8% | 49.2% | ||||
| Avg | 354.2% | 33.8% | ||||
| Low | 334.2% | 17.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.